Mobile Monitoring for Postoperative Complications
(COSMOS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for monitoring patients after major non-cardiac surgeries. It uses the GE Portrait Mobile Monitoring Solution, a mobile system, to track vital signs and determine if it can detect problems earlier. The trial includes two groups: one where the medical team accesses the monitoring data and another where they do not. It seeks participants planning to undergo major surgery lasting over 1.5 hours with an overnight hospital stay. Participants should not have conditions that complicate monitoring, such as significant hearing or vision problems.
As a Phase 2 trial, this research measures the effectiveness of the monitoring solution in an initial, smaller group, allowing participants to contribute to innovative healthcare solutions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the GE Portrait Mobile Monitoring Solution is safe for postoperative patients?
Research has shown that the GE Portrait Mobile Monitoring Solution is safe and easy for patients to use. A previous study found that this system effectively tracks changes in vital signs without causing harm. It provides real-time alerts about a patient's condition, reducing the risk of complications after surgery.
The device is wireless and wearable, offering convenience for patients. Studies have not reported any negative effects directly linked to this monitoring solution, suggesting it is safe for patients recovering from surgery. The device aims to improve patient outcomes by closely monitoring vital signs like breathing rate and oxygen levels, enabling healthcare providers to respond quickly if any issues arise.
Overall, the available safety data supports using the GE Portrait Mobile Monitoring Solution as a reliable tool for post-surgery care.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of continuous postoperative vital sign monitoring using the GE Portrait Mobile Monitoring Solution. Unlike traditional intermittent monitoring, this mobile solution offers constant, real-time data, which may help in early detection of complications after surgery. The trial includes two unique approaches: blinded monitoring, where data is hidden from clinicians, and unblinded monitoring, where data is visible to healthcare providers. Understanding the impact of continuous monitoring could lead to significant improvements in patient outcomes by allowing for quicker interventions and more personalized care.
What evidence suggests that the GE Portrait Mobile Monitoring Solution is effective for reducing vital sign abnormalities in postoperative patients?
Research has shown that the GE Portrait Mobile Monitoring Solution helps reduce unusual vital signs in patients recovering from major surgeries. In this trial, participants will be assigned to either a blinded or unblinded monitoring arm using this device. A small study found that continuous monitoring with this device lowered these abnormalities by 25%. Additionally, 82% of the alarms from the device proved helpful, prompting quick responses from healthcare staff. This indicates that the device can improve patient care by alerting nurses to important changes in a patient's condition. Overall, the evidence supports that this monitoring solution enhances care after surgery.13678
Who Is on the Research Team?
Daniel Sessler, MD
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are recovering from major noncardiac surgery that lasted at least 1.5 hours, will stay in the hospital overnight, and had general or neuraxial anesthesia. They should be in a physical condition rated between 1-4 by the American Society of Anesthesiologists.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Unblinded continuous ward monitoring with the GE Portrait Mobile Monitoring Solution and nursing alerts to reduce vital sign abnormalities during the initial 48 postoperative hours
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- GE Portrait Mobile Monitoring Solution
GE Portrait Mobile Monitoring Solution is already approved in European Union, United States for the following indications:
- Post-surgical monitoring
- Critical care monitoring
- Post-surgical monitoring
- Critical care monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor